genOway and Merck Strengthen CRISPR/Cas9 Strategic Alliance by...
LYON, France, Jan. 7, 2020 /PRNewswire-AsiaNet/ -- - genOway acquires additional rights to develop all animal cell models using the CRISPR/Cas9 systemgenOway, a public company and leader in developing genetically modified research models, today announced an important milestone in extending its...
Authors: LATEST ASIANET NEWS RELEASES